# Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

> **NCT01023815** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 330 (actual)

## Conditions studied

- de Novo Kidney Transplant Recipients
- Renal Transplantation

## Interventions

- **DRUG:** everolimus
- **DRUG:** cyclosporine
- **DRUG:** Prednison (continuous steroids)

## Key facts

- **NCT ID:** NCT01023815
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023815, "Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01023815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*